Considerations for infection risks identified in target safety review
The Journal of Toxicological Sciences · 2026 · 51 (4) · 251-258
DOI: 10.2131/jts.51.251 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Toxicological Sciences, 2026. Verfasst von Yuichiro Amano und 3 weiteren Autor:innen. Beteiligte Einrichtung: Nonclinical Safety and Pharmacology, Research, Takeda Pharmaceutical Company Limited. Hauptthemen laut MEDLINE: Biological Products, Drug-Related Side Effects and Adverse Reactions, Infections. Die Arbeit nennt 21 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Nonclinical Safety and Pharmacology, Research, Takeda Pharmaceutical Company Limited.
Zitieren
APA
Amano, Y., Inui, Y., Yoshioka, S., & Goodwin, J. (2026). Considerations for infection risks identified in target safety review. The Journal of Toxicological Sciences, 51(4), 251-258. https://doi.org/10.2131/jts.51.251
Vancouver
Amano Y, Inui Y, Yoshioka S, Goodwin J. Considerations for infection risks identified in target safety review. The Journal of Toxicological Sciences. 2026;51(4):251-258. doi:10.2131/jts.51.251
BibTeX
@article{Amano2026,
author = {Amano, Yuichiro and Inui, Yoshitaka and Yoshioka, Satoko and Goodwin, Jodi},
title = {Considerations for infection risks identified in target safety review},
journal = {The Journal of Toxicological Sciences},
year = {2026},
volume = {51},
number = {4},
pages = {251--258},
doi = {10.2131/jts.51.251}
}
EUVIMED